AMPIO PHARMACEUTICALS INC (AMPE)
Institutional ownership reported to the SEC as of Q1 2026, across 27 quarters.
1
Reporting holders
$67
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Cypress Capital Management LLC (WY) | $67 | 440 | 0.00% | 4q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q1 2026 | 1 | $67 | 440 | 0 | 0 | 0 | 0.0% |
| Q4 2025 | 1 | $2 | 440 | 0 | 0 | 0 | 0.0% |
| Q3 2025 | 1 | $1 | 440 | 0 | 0 | 0 | 0.0% |
| Q2 2025 | 1 | $1 | 440 | 1 | 0 | 0 | 0.0% |
| Q2 2024 | 3 | $13 | 133 | 0 | 0 | 1 | 0.0% |
| Q1 2024 | 27 | $30.6K | 33,303 | 1 | 3 | 2 | 0.0% |
| Q4 2023 | 27 | $684.3K | 32,505 | 3 | 4 | 2 | 90.3% |
| Q3 2023 | 27 | $1.1M | 2,347 | 27 | 0 | 1 | 99.2% |
| Q2 2023 | 32 | $129.1K | 257,247 | 3 | 3 | 5 | 53.7% |
| Q1 2023 | 31 | $127.9K | 243,586 | 5 | 3 | 7 | 55.6% |
| Q4 2022 | 30 | $266.7K | 319,894 | 30 | 0 | 0 | 73.1% |
| Q3 2022 | 83 | $1.8M | 29,528,474 | 4 | 10 | 22 | 3.4% |
| Q2 2022 | 104 | $5.6M | 30,465,778 | 18 | 16 | 20 | 3.9% |
| Q1 2022 | 126 | $23.5M | 48,597,487 | 6 | 19 | 32 | 3.2% |
| Q4 2021 | 132 | $35.0M | 59,464,760 | 13 | 33 | 33 | 3.3% |
| Q3 2021 | 123 | $74.8M | 44,217,140 | 7 | 31 | 29 | 2.9% |
| Q2 2021 | 128 | $78.5M | 45,183,272 | 36 | 26 | 23 | 4.0% |
| Q1 2021 | 111 | $54.4M | 30,423,229 | 18 | 33 | 16 | 5.3% |
| Q4 2020 | 103 | $46.2M | 25,807,959 | 24 | 30 | 12 | 11.5% |
| Q3 2020 | 83 | $18.6M | 18,450,468 | 14 | 24 | 8 | 5.9% |
| Q2 2020 | 80 | $11.7M | 17,521,314 | 12 | 20 | 11 | 4.1% |
| Q1 2020 | 76 | $7.2M | 16,420,986 | 10 | 14 | 11 | 3.9% |
| Q4 2019 | 78 | $9.3M | 15,744,989 | 8 | 12 | 12 | 1.7% |
| Q3 2019 | 75 | $6.5M | 12,631,079 | 9 | 15 | 9 | 2.4% |
| Q2 2019 | 81 | $8.4M | 20,527,365 | 13 | 13 | 19 | 4.8% |
| Q1 2019 | 87 | $11.2M | 19,573,715 | 8 | 16 | 14 | 1.9% |
| Q4 2018 | 89 | $7.8M | 19,126,203 | 3 | 1 | 2 | 3.1% |